The majority of antibiotics used globally are administered to farm animals, and evidence...
- Herd health: agriculture’s role in the global AMR crisis
- WHO’s Essential Medicines List: discussing innovation and access
- Can Pharmaoffer become the Amazon of pharma raw materials?
- How automation and man-machine collaboration is reshaping blood storage
- Novartis defends Zolgensma in face of FDA’s data concerns
Kinaxis Reimagines Supply Chain Ecosystems
Kinaxis Inc, a leader in influencing individuals to make self-assured supply chain decisions, has expanded its RapidResponse platform to become the only concurrent planning platform with the power to generate custom, interconnected applications and algorithms and operationalise external algorithms in practical, profitable ways across the supply chain ecosystem.
Butterworth’s Statement on Brexit
Butterworth Laboratories Ltd, a UK-based a contract analytical chemistry testing laboratory working principally in the pharmaceutical market, has been continuously monitoring Brexit and its potential outcome over the last 12 months.
Herd health: agriculture’s role in the global AMR crisis
The majority of antibiotics used globally are administered to farm animals, and evidence is showing the impact it’s having on the antimicrobial resistance crisis. How does the animal-focused pharma industry feed into AMR in humans, and what are the alternatives to important shared-use antibiotics?
AirBridgeCargo Airlines is Re-Certified for IATA CEIV Pharma
AirBridgeCargo Airlines has successfully gained its IATA CEIV Pharma re-certification following two-day audit procedures for compliance with IATA’s Center of Excellence for Validators in Pharmaceutical Logistics (CEIV Pharma) certification program.
WHO’s Essential Medicines List: discussing innovation and access
Since 1977, the WHO’s Essential Medicines List has provided an important guide to help countries prioritise their own drug procurement. But how does the list operate in the 21st century, and in what ways does it impact the global pharmaceutical industry?
UK’s NAO warns of uncertain medicines supply in no-deal Brexit
A report by the National Audit Office (NAO), UK has warned that a no-deal Brexit still poses a threat to the supply of medicines, indicating the need for more measures to ensure adequate supply.
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.